The increasing potency of immunosuppression (IS) agents resulted in significantly
decreased rates of steroid resistant rejection and rejection related graft loss in liver …

Post-liver transplantation diabetes mellitus (PLTDM) develops in up to 30% of liver
transplant recipients and is associated with increased risk of mortality and multiple morbid …

Dramatic improvement in first‐year outcomes post‐liver transplantation (LT) has shifted
attention to long‐term survival, where efforts are now needed to achieve improvement …

We report the results of a study of survival, liver and kidney functions, and growth with a
median follow-up of 24 years following liver transplantation in childhood. From 1988 to …

Background Short-term survival after orthotopic liver transplantation (OLT) has improved
over the past decades, but long-term survival remains impaired. The effects of obesity on …

Liver diseases during pregnancy pose a unique clinical challenge as they can affect the
lives of both the mother and unborn child. Although severe liver disease is rare, pregnancy …

De novo neoplasms account for almost 30% of deaths 10 years after liver transplantation
and are the most common cause of mortality in patients surviving at least 1 year after …

Background As part of liver transplantation, immunosuppression (suppressing the host
immunity) is given to prevent graft rejections resulting from the immune response of the body …

Liver diseases impose a huge burden worldwide. Although hepatocyte transplantation has
long been considered as a potential strategy for treating liver diseases, its clinical …

Background. Mortality from cirrhosis is increasing and is the highest among young adults
with alcohol-associated liver disease (ALD). The aim of this study was to describe rates of …